nvjc ep. 20 myasthenia gravis / als / neuromuscular: use of whole-genome sequencing
Published 1 year ago • 1.1K plays • Length 43:39Download video MP4
Download video MP3
Similar videos
-
32:10
nvjc ep. 19 myasthenia gravis/als/neuromuscular: anti-hu antibodies in patients
-
19:12
nvjc ep. 21 myasthenia gravis/als/neuromuscular: sars-cov-2 vaccination safety in guillain-barré
-
23:42
nvjc ep. 18 myasthenia gravis/als/neuromuscular: neuromuscular features in xl-mtm carriers
-
25:49
nvjc ep. 58 myasthenia gravis/als/neuromuscular: safety & efficacy of nipocalimab in patients w/ mg
-
11:41
panduan alat hematologi autoanalyzer sysmex kx-21
-
16:53
nvjc ep. 24 myasthenia gravis/als/neuromuscular: randomized double-blind placebo-controlled trial
-
1:41:24
sig neuromuscular disorders session 2
-
28:21
nvjc ep. 59 myasthenia gravis/als/neuromuscular: secondary generalization in patients with ocular mg
-
1:06
tex20 demo series - smart ivc
-
31:36
is whole exome sequencing (wes) the answer to end the diagnostic odyssey in rare diseases?
-
1:02
comparison between whole genome sequencing, whole exome sequencing and microarray
-
1:18
pharmacological inhibition of c1q in multiple sclerosis
-
0:58
mhc ii
-
1:05
sysmex at medlab asia and asia health 2022
-
1:22
exciting upcoming mpns trials: v617f-targeted jak2 inhibitors and anti-calreticulin antibodies
-
33:39
whole genome sequencing and precision medicine
-
1:36
05 - what is whole genome sequencing
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm